| Primary |
| Urticaria |
40.0% |
| Nonspecific Reaction |
20.0% |
| Rash |
20.0% |
| Seasonal Allergy |
20.0% |
|
| Accidental Overdose |
45.6% |
| Overdose |
12.8% |
| No Adverse Event |
12.0% |
| Accidental Exposure To Product By Child |
11.2% |
| Somnolence |
4.0% |
| Medication Error |
1.6% |
| Product Taste Abnormal |
1.6% |
| Psychomotor Hyperactivity |
1.6% |
| Accidental Exposure To Product |
0.8% |
| Adverse Event |
0.8% |
| Cardiac Operation |
0.8% |
| Conversion Disorder |
0.8% |
| Cough |
0.8% |
| Diarrhoea |
0.8% |
| Fatigue |
0.8% |
| Heart Rate Increased |
0.8% |
| Incorrect Route Of Drug Administration |
0.8% |
| Intentional Overdose |
0.8% |
| Mydriasis |
0.8% |
| Screaming |
0.8% |
|
| Secondary |
| Drug Use For Unknown Indication |
55.6% |
| Chronic Sinusitis |
22.2% |
| Antiallergic Therapy |
11.1% |
| B-cell Lymphoma |
11.1% |
|
| Abortion Spontaneous |
25.0% |
| Accidental Overdose |
25.0% |
| Overdose |
25.0% |
| Polyneuropathy |
25.0% |
|
| Concomitant |
| Drug Use For Unknown Indication |
30.4% |
| Diffuse Large B-cell Lymphoma |
20.1% |
| Product Used For Unknown Indication |
17.4% |
| Nausea |
3.2% |
| Pain |
3.0% |
| Premedication |
2.6% |
| Abdominal Pain |
2.4% |
| Vitamin Supplementation |
2.4% |
| Prophylaxis |
2.2% |
| B-cell Lymphoma |
2.0% |
| Crohn's Disease |
2.0% |
| Reflux Oesophagitis |
2.0% |
| Atrial Fibrillation |
1.8% |
| Vomiting |
1.6% |
| Prostate Cancer |
1.4% |
| Hypertension |
1.2% |
| Breast Cancer |
1.0% |
| Constipation |
1.0% |
| Nodular (Follicular) Lymphoma |
1.0% |
| Arthritis |
0.8% |
|
| Deep Vein Thrombosis |
8.3% |
| Gastric Perforation |
8.3% |
| Glioblastoma Multiforme |
8.3% |
| Hip Fracture |
8.3% |
| Tremor |
8.3% |
| Ascites |
6.3% |
| Abortion Spontaneous |
4.2% |
| Arrhythmia |
4.2% |
| Cellulitis |
4.2% |
| Flushing |
4.2% |
| Nausea |
4.2% |
| Oedema Peripheral |
4.2% |
| Pain |
4.2% |
| Pneumonia |
4.2% |
| Splenomegaly |
4.2% |
| Swollen Tongue |
4.2% |
| Urticaria |
4.2% |
| Acute Myocardial Infarction |
2.1% |
| Congestive Cardiomyopathy |
2.1% |
| Dry Eye |
2.1% |
|
